Cleared Traditional

K904539 - FLAGEN TM FREE T4

K904539 is the FDA 510(k) clearance for FLAGEN TM FREE T4 by Cyberfluor, Inc.. It is a Class 2 Chemistry device (product code CEC) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K904539 · Cyberfluor, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1990
Decision
57d
Days
Class 2
Risk

K904539 is an FDA 510(k) clearance for the FLAGEN TM FREE T4. Classified as Radioimmunoassay, Free Thyroxine (product code CEC), Class II - Special Controls.

Submitted by Cyberfluor, Inc. (Ontario M5t 1x4, CA). The FDA issued a Cleared decision on November 30, 1990 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1695 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cyberfluor, Inc. devices

Submission Details

510(k) Number K904539 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 1990
Decision Date November 30, 1990
Days to Decision 57 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 88d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEC Radioimmunoassay, Free Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1695
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEC Radioimmunoassay, Free Thyroxine

All 64
Devices cleared under the same product code (CEC) and FDA review panel - the closest regulatory comparables to K904539.
AFFINITY FREE T4 TEST SYSTEM
K912698 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1991
MICROZYME(TM) FREE T4 ENZYME IMMUNOASSAY TEST
K911634 · Immunotech Corp. · Jun 1991
CIBA CORNING ACS FT4 IMMUNOASSAY
K910684 · Ciba Corning Diagnostics Corp. · May 1991
TDX FREE T4 CALCULATION
K903383 · Abbott Laboratories · Sep 1990
IMX FREE T4 CALCULATION
K903384 · Abbott Laboratories · Sep 1990
ABBOTT IMX FREE T4
K902834 · Abbott Laboratories · Sep 1990